Clinical trials data
Complex Figure Copy and Recall in dementia and Alzheimer's trials: 53 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names Complex Figure Copy and Recall in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 53
- Name it in a primary outcome, 43%
- 23 of 53
Tests named in the same studies
- 1
Trail Making Test38 studies, 17 as a primary outcome
- 2
Verbal Learning32 studies, 15 as a primary outcome
- 3
Verbal Fluency31 studies, 13 as a primary outcome
- 4
Digit Span Test27 studies, 13 as a primary outcome
- 5
Stroop Color-Word Test18 studies, 11 as a primary outcome
- 6
Picture Naming Test15 studies, 8 as a primary outcome
- 7
Symbol Coding12 studies, 6 as a primary outcome
- 8
Category Fluency11 studies, 6 as a primary outcome
- 9
Clock Drawing Task11 studies, 6 as a primary outcome
- 10
Short Story Recall11 studies, 4 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 3 | 1 |
| 2018 | 2 | 2 |
| 2019 | 4 | 3 |
| 2020 | 3 | 3 |
| 2021 | 2 | 2 |
| 2022 | 3 | 1 |
| 2023 | 5 | 1 |
| 2024 | 9 | 3 |
| 2025 | 7 | 3 |
| 2026 | 3 | 0 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 11 studies, 1 as a primary outcome
- Phase 1/22 studies, 1 as a primary outcome
- Phase 26 studies, 2 as a primary outcome
- Phase 31 studies, 0 as a primary outcome
- Phase 41 studies, 0 as a primary outcome
- Not applicable27 studies, 10 as a primary outcome
- Observational14 studies, 9 as a primary outcome
Participants per study
- Not applicable61 median, 46 to 171
- Observational310 median, 156 to 750
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 27 | 61 | 46 to 171 |
| Observational | 13 | 310 | 156 to 750 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day5 outcomes, 4 as a primary outcome
- Up to 4 weeks4 outcomes, 0 as a primary outcome
- 1 to 3 months5 outcomes, 3 as a primary outcome
- 3 to 6 months12 outcomes, 6 as a primary outcome
- 6 to 12 months15 outcomes, 4 as a primary outcome
- 1 to 2 years2 outcomes, 0 as a primary outcome
- Over 2 years7 outcomes, 4 as a primary outcome
- No duration given3 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
50 of the 53 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting11 studies, 3 as a primary outcome
- Not yet recruiting4 studies, 2 as a primary outcome
- Completed25 studies, 11 as a primary outcome
- Stopped early3 studies, 2 as a primary outcome
- Status unknown10 studies, 5 as a primary outcome
What they test
- Behavioral15 studies, 8 as a primary outcome
- Drug11 studies, 3 as a primary outcome
- Device11 studies, 4 as a primary outcome
- Dietary supplement1 studies, 0 as a primary outcome
- Procedure1 studies, 0 as a primary outcome
- Diagnostic test2 studies, 1 as a primary outcome
- Other10 studies, 1 as a primary outcome
- None given9 studies, 6 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- Italy13 studies, 5 as a primary outcome
- China10 studies, 5 as a primary outcome
- United States10 studies, 7 as a primary outcome
- Canada3 studies, 1 as a primary outcome
- Taiwan3 studies, 1 as a primary outcome
- France2 studies, 0 as a primary outcome
- Spain2 studies, 1 as a primary outcome
- Sweden2 studies, 1 as a primary outcome
- Austria1 studies, 0 as a primary outcome
- Belgium1 studies, 0 as a primary outcome
- Brazil1 studies, 0 as a primary outcome
- Bulgaria1 studies, 0 as a primary outcome
24 countries in all. A study with sites in several counts in each; 2 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name Complex Figure Copy and Recall: 16 of 25, 64%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name Complex Figure Copy and Recall | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 6, 24% | 776, 10% |
| Results on ClinicalTrials.gov only | 3, 12% | 1,139, 14% |
| A results paper only | 7, 28% | 1,711, 22% |
| Neither | 9, 36% | 4,327, 54% |
The 53 studies
53 studies match. 23 name Complex Figure Copy and Recall in a primary outcome. Median size 78 participants. Median time to the primary outcome: 6 months.
Loading 53 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 3 | 1 |
| 2018 | 2 | 2 |
| 2019 | 4 | 3 |
| 2020 | 3 | 3 |
| 2021 | 2 | 2 |
| 2022 | 3 | 1 |
| 2023 | 5 | 1 |
| 2024 | 9 | 3 |
| 2025 | 7 | 3 |
| 2026 | 3 | 0 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 2, other 51. Interventional 39, observational 14.
As a primary outcomeSecondary or other outcomeComplex Figure Copy and Recall
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07883148 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants52 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07882251 | Start2021 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07731334 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants384 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07664865 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants250 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07629349 | Start2020 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07399418 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07375771 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07135245 | Start2026 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants180 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07087951 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants70 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06902753 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Hearing loss | Participants120 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06875739 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Parkinson's disease | Participants310 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06869135 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Parkinson's disease | Participants242 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06733714 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06715995 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants52 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06694597 | Start2023 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants76 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06215274 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants156 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06181513 | Start2022 | PhaseEarly phase 1 | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06181500 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants13 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06022068 | Start2023 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants14 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05887674 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants180 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05730023 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05647473 | Start2024 | PhasePhase 2 | ConditionsDementia and Alzheimer's, Cardiovascular disease | Participants66 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05623124 | Start2021 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants400 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use Complex Figure Copy and Recall?
53 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 23 of them in a primary outcome: 3% of the condition's 1,673 studies with a cognitive outcome, against 2% of all of them. It is the 13th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with Complex Figure Copy and Recall?
The Trail Making Test (38 studies), Verbal Learning (32 studies) and Verbal Fluency (31 studies).
When do dementia and Alzheimer's trials measure Complex Figure Copy and Recall?
Half of the primary outcomes that name Complex Figure Copy and Recall are measured within 6 months of the start, and the middle half from 12 weeks to 12 months. 21 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use Complex Figure Copy and Recall have reported results?
16 of the 25 completed studies that name it, 64%, have reported results: 9 posted them on ClinicalTrials.gov, 13 have a results paper linked to the registry record, and 6 did both. The other 9 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run Complex Figure Copy and Recall in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.